Letter to the Editor Re: Ahn DH, Krishna K, Blazer M, et al. “A modified regimen of biweekly gemcitabine and nab-paclitaxel in patients with metastatic pancreatic cancer is both tolerable and effective: a retrospective analysis.” Ther Adv Med Oncol https://doi.org/10.1177/1758834016676011

Detalles Bibliográficos
Autores principales: Von Hoff, Daniel D, Renschler, Markus F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455879/
https://www.ncbi.nlm.nih.gov/pubmed/28607582
http://dx.doi.org/10.1177/1758834017699772

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455879/
https://www.ncbi.nlm.nih.gov/pubmed/28607582
http://dx.doi.org/10.1177/1758834017699772

Ejemplares similares